REDDSTAR researchers from NUI Galway, Orbsen Therapeutics Ltd., Ludwig-Maximilians-Universität München, University of Porto, Queen’s University Belfast, Miltenyi Biotec, Pintail Ltd., Steno Diabetes Center and Leiden University Medical Center attended the EU-MSC2 meeting in Leiden on the 7th and 8th of September 2015.
The two-day meeting brought together researchers from nine EU-funded projects pursuing MSC research. In addition to REDDSTAR, other projects represented at the meeting included Stellar, RETHRIM, REACH, VISICORT, ADIPOA-2, MERLIN, SCIENCE and NEPHSTROM. After a welcome from Henri Lenferink, Mayor of Leiden, European Commission Project Officer Dr. Charles Kessler highlighted the EU’s continued support to regenerative medicine research, and a Fundamental MSC Biology lecture was delivered by Prof. Dr. Yufang Shi from the Institute of Health Sciences, Shanghai, China. Following on, the nine EU-funded projects were presented.
On the second day of the meeting, interactive panel discussions about key challenges faced when developing MSC therapies, including scientific obstacles, regulatory and ethical issues, technological hurdles and commercialisation barriers ensued. Opportunities for future collaborations and the harmonisation of MSC research in Europe were discussed. A public meeting report will follow.